Homocysteine Levels and Treatment Effect in the Prospective Study of Pravastatin in the Elderly at Risk

Homocysteine and Coronary Heart Disease: Meta-analysis of MTHFR Case-Control Studies, Avoiding Publication Bias

(2012) Robert Clarke et al.   PLOS MEDICINE

Homocysteine and Cardiovascular Risk

(2011) Arduino A. Mangoni et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Homocysteine and Reclassification of Cardiovascular Disease Risk

(2011) Vikas Veeranna et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study

(2011) Heart Protection Study Collaborative Group   LANCET

Screening for Future Cardiovascular Disease Using Age Alone Compared with Multiple Risk Factors and Age

(2011) Nicholas J. Wald et al.   PLoS One

Meta-Analysis of Folic Acid Supplementation Trials on Risk of Cardiovascular Disease and Risk Interaction With Baseline Homocysteine Levels

(2010) Edgar R. Miller et al.   AMERICAN JOURNAL OF CARDIOLOGY

Effects of Lowering Homocysteine Levels With B Vitamins on Cardiovascular Disease, Cancer, and Cause-Specific MortalityMeta-analysis of 8 Randomized Trials Involving 37 485 IndividualsEffects of Lowering Homocysteine Levels

(2010)   ARCHIVES OF INTERNAL MEDICINE

Heart Disease and Stroke Statistics—2009 Update

(2009) et al.   CIRCULATION

Homocysteine Level and Coronary Heart Disease Incidence: A Systematic Review and Meta-analysis

(2009) Linda L. Humphrey et al.   MAYO CLINIC PROCEEDINGS

Reduced Glomerular Filtration Rate and Its Association with Clinical Outcome in Older Patients at Risk of Vascular Events: Secondary Analysis

(2009) Ian Ford et al.   PLOS MEDICINE